BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23721273)

  • 1. Screening for cervical cancer in low-resource settings in 2011.
    Tambouret R
    Arch Pathol Lab Med; 2013 Jun; 137(6):782-90. PubMed ID: 23721273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cervical cancer in low-resource settings in 2011.
    Patrizzi B
    Arch Pathol Lab Med; 2014 Feb; 138(2):156. PubMed ID: 24476514
    [No Abstract]   [Full Text] [Related]  

  • 3. In reply.
    Tambouret R; Roberts DJ
    Arch Pathol Lab Med; 2014 Feb; 138(2):156. PubMed ID: 24476513
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer: a call for political will.
    Pollack AE; Balkin MS; Denny L
    Int J Gynaecol Obstet; 2006 Sep; 94(3):333-42. PubMed ID: 16857201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review.
    Williams-Brennan L; Gastaldo D; Cole DC; Paszat L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1487-505. PubMed ID: 23011733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of abnormal uterine bleeding in low- and high-resource settings: consideration of cultural issues.
    Haththotuwa R; Goonewardene M; Desai S; Senanayake L; Tank J; Fraser IS
    Semin Reprod Med; 2011 Sep; 29(5):446-58. PubMed ID: 22065330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's perspectives on cervical screening and treatment in developing countries: experiences with new technologies and service delivery strategies.
    Bradley J; Coffey P; Arrossi S; Agurto I; Bingham A; Dzuba I; Kleine AN; Lewis R; White SC
    Women Health; 2006; 43(3):103-21. PubMed ID: 17194680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies in cervical cancer screening.
    Gravitt PE; Coutlée F; Iftner T; Sellors JW; Quint WG; Wheeler CM
    Vaccine; 2008 Aug; 26 Suppl 10():K42-52. PubMed ID: 18847556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of cervical-cancer screening in five developing countries.
    Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
    N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of rural women's knowledge, constraints and perceptions on cervical cancer screening: the case of two districts in Zimbabwe.
    Mangoma JF; Chirenje MZ; Chimbari MJ; Chandiwana SK
    Afr J Reprod Health; 2006 Apr; 10(1):91-103. PubMed ID: 16999199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of cancer of the cervix in low- and middle-income countries.
    Denny L
    Ann Surg Oncol; 2015 Mar; 22(3):728-33. PubMed ID: 25605513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative cervical cancer prevention in low-resource settings: Experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
    Palanuwong B
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):54-60. PubMed ID: 17261102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.